Merck KGaA (FRA:MRK) has been given a consensus rating of “Hold” by the twenty-three research firms that are currently covering the firm. One investment analyst has rated the stock with a sell recommendation, eleven have assigned a hold recommendation and eleven have given a buy recommendation to the company. The average 1 year price target among brokerages that have covered the stock in the last year is €101.10 ($112.33).

MRK has been the topic of a number of research analyst reports. Baader Bank set a €97.00 ($107.78) target price on Merck KGaA and gave the company a “neutral” rating in a research report on Thursday, June 9th. BNP Paribas set a €108.00 ($120.00) price objective on Merck KGaA and gave the stock a “buy” rating in a research report on Thursday, June 9th. Bankhaus Lampe set a €102.00 ($113.33) price objective on Merck KGaA and gave the stock a “buy” rating in a research report on Friday, June 17th. Morgan Stanley set a €92.00 ($102.22) price objective on Merck KGaA and gave the stock a “sell” rating in a research report on Tuesday, June 21st. Finally, DZ Bank AG reaffirmed a “buy” rating on shares of Merck KGaA in a research report on Thursday, July 14th.

Shares of Merck KGaA (FRA:MRK) traded down 0.613% during mid-day trading on Friday, reaching €95.825. The company’s stock had a trading volume of 26 shares. Merck KGaA has a 52 week low of €70.87 and a 52 week high of €100.00. The company’s 50-day moving average is €95.79 and its 200-day moving average is €89.16. The stock has a market capitalization of €41.66 billion and a price-to-earnings ratio of 29.983.

Merck KGaA Company Profile

.

Receive News & Stock Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related stocks with our FREE daily email newsletter.